1) pleural effusion/drug therapy
胸腔积液护理
2) Pleural effusion
胸腔积液
1.
Systemic chemotherapy combined with intrathoracic sequent immunotherapy for patients with malignant pleural effusion due to non-small cell lung cancer (NSCLC);
双路化疗免疫序贯治疗非小细胞肺癌胸腔积液
2.
Pleural effusion caused by bronchial fluke;
肺吸虫病引起的胸腔积液
3) Malignant pleural effusion
胸腔积液
1.
Clinical evaluation of radio-heating-chemotherapy in treatment of patients with malignant pleural effusion;
射频透热联合化疗治疗恶性胸腔积液的临床评价
2.
Objective To observe the therapeutic efficacy of intraplearal injection of kanserin in the treatment of malignant pleural effusion.
目的探讨康赛宁腔内注射治疗恶性胸腔积液的临床疗效。
4) hydrothorax
[英][,haidrə'θəuræks] [美][,haɪdrə'θoræks]
胸腔积液
1.
Mesothelial Cell,CEA,CK and Vimentin in Diagnosis of Hydrothorax:A Study of Clinical Value;
间皮细胞、癌胚抗原、角蛋白、波型蛋白在胸腔积液临床诊断中的作用
2.
Significance of Combinatory Detection of Hydrothorax ProgastrinReleasing Peptide and Carcino-embryonic Antigen in Diagnosisof Lung Cancer Complicated with Malignant Pleural Effusion;
胸水ProGRP及CEA联合检测在肺癌并发恶性胸腔积液诊断中的价值
3.
The Value of Ultrasonography in the Diagnosis of Hydrothorax;
超声在胸腔积液中的诊断价值
5) Pleural effusions
胸腔积液
1.
Comparison of the diagnostic value of DNA analysis and CEA and SF level in benign and malignant pleural effusions;
DNA倍体分析、癌胚抗原、铁蛋白对良恶性胸腔积液诊断价值的研究
2.
Value of combined measurements of chromosome and adenosine deaminase (ADA) for identification of benign and malignant pleural effusions;
联合检测染色体及腺苷脱氨酶对鉴别良恶性胸腔积液的价值
3.
Expression of soluble interleukin 2 receptor and tumor necrosis factor in pleural effusions;
可溶性白介素2受体与肿瘤坏死因子在胸腔积液中的表达
6) Pleural fluid
胸腔积液
1.
Expressions and significances of CEA and CA199 in pleural fluid of patients with lung adenocarcinoma;
肺腺癌患者胸腔积液中CEA和CA199的表达及意义
2.
\ Methods\ The levels of CEA, CYFRA 21 1 and NSE were detected both in serum and pleural fluid of patients with pleural effusion by means of immunoradiometric assay.
①目的 探讨测定癌胚抗原 (CEA)、非小细胞肺癌标志物 (CYFRA2 1 1)和神经元特异性烯醇化酶(NSE)对良恶性胸腔积液的鉴别诊断价值。
3.
Objective: To investigate the effectives of Bleomycin and Interleukin II (IL-II) injected into thoracic cavity by central venous catheter (CVC) in the treatment of malignant pleural fluid.
本研究在此基础上对40例恶性胸腔积液患者胸腔内随机注入博莱霉素与白细胞介素Ⅱ,旨在对两种药物的治疗效果进行对比研究。
补充资料：癌性胸腔积液
癌性胸腔积液
malignant pleural effusion
指因胸膜、纵隔、肺原发或转移性肿瘤，致胸膜渗出增多，淋巴与静脉回流障碍引起的胸膜腔积液。多具有血性、低度渗出性，积液量大和渗出迅速等特点。治疗可穿刺抽液，闭式引流，胸内注射抗癌药或四环素封闭胸膜腔。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条